UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 25, 2015

 

 

 

AMARANTUS BIOSCIENCE HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada 333-148922 26-0690857
(State or other jurisdiction of incorporation or organization) (Commission File Number)

IRS Employer

Identification No.)

 

655 Montgomery Street

Suite 900

San Francisco, CA

94111
(Address of Principal Executive Offices) (Zip Code)

 

(408) 737-2734

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 8.01

Other Events

 

On February 25, 2015, a Stipulation of Dismissal with Prejudice in connection with Reginicin, Inc. v. Lonza Walkersville, Inc. et al Case No. 1:13-cv-3596 was filed in United States District Court for the District of New Jersey pursuant to the Settlement Agreement dated February 23, 2015 by and among Amarantus Bioscience Holdings, Inc., Lonza Group, Ltd., Lonza America, Inc. and Lonza Walkersville, Inc.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AMARANTUS BIOSCIENCE HOLDINGS, INC.
       
Date: February 26, 2015 By: /s/ Gerald E. Commissiong  
    Name: Gerald E. Commissiong
    Title: Chief Executive Officer

 

 

Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Amarantus Bioscience (CE) Charts.
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Amarantus Bioscience (CE) Charts.